Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%
The Pharma Data
NOVEMBER 16, 2020
A single pill also is cheaper to market and distribute. Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. If it’s more convenient together, why not?”
52 
Let's personalize your content